Similarly, in-frame deletion mutations involving exons 2-8, which includes the Ras-binding domain, were also detected in D/T combination-resistant BRAF melanomas in patients, albeit at a low frequency of 0.4% [41]. The gene discussed is BRAF; the disease is melanoma.